News
BOIRON : Activité du premier semestre 2017
ACTIVITÉ BOIRON PREMIER SEMESTRE 2017
(Données non auditées)
ACTIVITÉ CUMULÉE À FIN JUIN 2017
en milliers d'euros
2016
2017
Var. taux courant 2017/2016
Var. taux constant....
BOIRON : 2017 half-year activity
BOIRON 2017 HALF-YEAR ACTIVITY
(Unaudited data)
CUMULATIVE ACTIVITY AS OF THE END OF JUNE 2017
in thousands of euros
2016
2017
Variation at current exchange rates
Variation....
Why Sarepta Therapeutics Stock Rose After-Hours Wednesday
Shares of the orphan drug specialist Sarepta Therapeutics (NASDAQ: SRPT) rose by as much as 15.5% in after-hours trading yesterday on heavy volume. This double-digit rally was sparked by a far
Why Sarepta Therapeutics Stock Is Rising Today
Shares of the orphan drug specialist Sarepta Therapeutics (NASDAQ: SRPT) rose by as much as 15.5% in after-hours trading yesterday on heavy volume. This double-digit rally was sparked by a far
Vertex Pharmaceuticals Stock Is Soaring: Here's Why It's Still Not Too Late to Buy
Just last week, I wrote why you'd be smart to buy Vertex Pharmaceuticals (NASDAQ: VRTX) stock. At that time, Vertex was up around 70% for the year. My argument then was that the stock was still
Here's Why Inovio Pharmaceuticals, Inc. Stock Fell Today
Shares of Inovio Pharmaceuticals, Inc. (NASDAQ: INO), a clinical-stage biotech with a focus on cancer and infectious diseases, fell 13.4% during Wednesday's session. An announcement on Tuesday that
5 Off-the-Radar Numbers to Take Note of in Johnson & Johnson's Second-Quarter Report
It's officially earnings season, which can only mean one thing: Johnson & Johnson (NYSE: JNJ) is kicking things off for big pharmaceutical companies.On Tuesday morning, July 18, Johnson & Johnson
Valeant Just Showed Why Its Share Price Has Deservedly Fallen by 93% Since August 2015
Most drug companies have been relatively unstoppable over the past couple of years, partly because of the optimism surrounding a stock market that keeps hitting new all-time highs, and partly due to
Here's Why AVEO Oncology Rose as Much as 15% Today
Shares of biopharma AVEO Oncology (NASDAQ: AVEO) rose up to 15% this morning as the nearly monthlong momentum continued to keep the roller-coaster ride going. While there has been a steady
Why Vertex Pharmaceuticals Incorporated Stock Is Soaring Today
Shares of rare-disease drugmaker Vertex Pharmaceuticals (NASDAQ: VRTX) are on the rise this morning thanks to the extremely positive data readouts for three trials assessing three different triple
3 Big Pharma Companies With the Best Projected Return on Investment
Some projections are easier than others. Research firm EvaluatePharma recently published its report of where the pharmaceutical industry could be in 2022. One of the firm's projections was which big
These 4 Marijuana Stocks All Jumped at Least 10% Last Week
The legal marijuana industry has been a monster in terms of growth, and marijuana stock investors have taken notice. In fact, a majority of pot stocks have doubled or tripled in value over the
3 Stocks to Supplement Your Social Security Income
Most American retirees depend on Social Security for at least half their retirement income. While it has been a reliable source of income for generations, Social Security's future looks a lot shakier
Better Buy: Celldex Therapeutics, Inc. vs. Juno Therapeutics
Celldex Therapeutics (NASDAQ: CLDX) and Juno Therapeutics (NASDAQ: JUNO) are both once-promising clinical-stage biotechs that have fallen on extremely hard times of late. Over the past two and half
Does Puma Biotechnology's Approval Make It Worth More?
Puma Biotechnology's (NASDAQ: PBYI) roller-coaster ride to approval is finally over. After fits and starts in clinical trials, the FDA gave the company's breast cancer drug, Nerlynx, a green light
How Risky Is Organovo Holdings, Inc.?
You probably won't be shocked to learn that Organovo Holdings, Inc. (NASDAQ: ONVO) has historically been a risky stock. After all, the share price of the 3D bioprinting company dropped nearly 36% in
Here's Why Quidel Corporation Is Rising Today
Shares of Quidel Corporation (NASDAQ: QDEL), a company focused on diagnostic testing equipment, rose 11% as of 11:45 a.m. EDT on Tuesday in response to the announcement that it is acquiring a few
Here's Why Novavax, Inc. Stock Popped Today
Shares of Novavax, Inc. (NASDAQ: NVAX), a clinical-stage biotech focused on novel vaccine development, jumped 24.6% higher as of 11:50 a.m. EDT on Tuesday. Investors are cheering in response to the
Despite Falling Drug Sales, Johnson & Johnson Remains Optimistic
Johnson & Johnson (NYSE: JNJ) owes much of its recent success to the strength of its pharmaceutical division. Even though the company also has extensive exposure to other parts of the healthcare
AveXis Inc.: Buy at the High?
In the time it takes most newborns to sprout their first teeth, AveXis Inc. (NASDAQ: AVXS) looks ready to sink its teeth into the biotech industry. Since its market debut in early 2016, stellar
5 Big Pharma Stocks With the Best Drug Pipelines
Big pharma companies can't rest on their laurels. Continual research and development is critical to ensure long-term success. Some of that R&D pays off more than others, though.Market research firm
5 Ways Gilead Sciences Could Spend Its Cash Hoard
Gilead Sciences (NASDAQ: GILD) has a growth problem.Long known for its enormous HIV franchise and market share, Gilead branched out into hepatitis C (HCV) in 2012. While that market provided plenty of
These 2 Companies Have No Competition
Warren Buffett has long championed the idea of investing in companies with durable competitive advantages. He believes that a business with true "moat" can more easily defend its market share from
Forget GW Pharmaceuticals: These 2 Stocks Are Better Buys
Yes, GW Pharmaceuticals (NASDAQ: GWPH) is the biggest marijuana-focused biotech stock on the market. The company's promising cannabinoid Epidiolex could very well become a blockbuster success story in
3 Healthcare Stocks for Ambitious Investors
While we Fools generally prefer to invest in companies that have battle-tested business models, we do recognize that it can be a smart idea to swing for the fences every now and then.So which stocks